International journal of cardiology · 2025
Impact of diagnosis-to-ablation time on rhythm outcome after catheter ablation for paroxysmal versus non-paroxysmal atrial fibrillation.
СтатьяСравнительное исследованиеПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Okuyama Takafumi, Watanabe Tomonori, Hoshide Satoshi, Suda Naoki, Watanabe Hiroaki, Kamioka Masashi, Makimoto Hisaki, Yokota Ayako, Komori Takahiro, Kabutoya Tomoyuki, Imai Yasushi, Kario Kazuomi
Аннотация
BACKGROUND AND AIMS: The difference of the impact of the diagnosis-to-ablation time (DAT) on rhythm outcome after catheter ablation (CA) between paroxysmal and non-paroxysmal atrial fibrillation (AF) remains undetermined. This study was designed to clarify the impact of DAT on outcome after the initial CA among AF types.
METHODS: We enrolled 619 patients (age 63 ± 11 years; 72 % male; 34 % non-paroxysmal AF) who underwent initial CA at our institute (Jan 2018-Dec 2022). The relationship between the DAT and recurrence after CA among AF types was investigated.
RESULTS: During the median 1038-day follow-up, 165 patients had AF recurrence. They had a higher percentage of non-paroxysmal AF (49.1 % vs. 29.4 %; p < 0.001), larger left atrium-diameter (mean 42 vs. 40 mm; p = 0.002) and longer DAT (median 1.7 vs. 0.8 years; p < 0.001) than those without recurrence. In COXproportional hazard analysis adjusted by confounders, the group with DAT ≥ 1 year, the optimal cutoff defined using receiver-operating characteristic curve analysis for recurrence, independently had a 2.3-fold greater risk of recurrence compared to the group without (p < 0.001). In a separate analysis with adjustment by confounders, paroxysmal and non-paroxysmal AF patients with DAT ≥ 1 year had 1.8-fold greater risk (p = 0.010) and 3.0-fold greater risk (p < 0.001), respectively, compared to those without. With respect to DAT-tertiles, paroxysmal AF patients in the top DAT-tertile (median 4.0 years) had 2.0-fold greater recurrence risk (p = 0.016), and non-paroxysmal AF patients in the top DAT-tertile had 4.0-fold greater recurrence risk, than those in the lowest DAT-tertile (p = 0.001).
CONCLUSION: AF patients with a longer DAT had a worse rhythm outcome after CA irrespective of AF type.
METHODS: We enrolled 619 patients (age 63 ± 11 years; 72 % male; 34 % non-paroxysmal AF) who underwent initial CA at our institute (Jan 2018-Dec 2022). The relationship between the DAT and recurrence after CA among AF types was investigated.
RESULTS: During the median 1038-day follow-up, 165 patients had AF recurrence. They had a higher percentage of non-paroxysmal AF (49.1 % vs. 29.4 %; p < 0.001), larger left atrium-diameter (mean 42 vs. 40 mm; p = 0.002) and longer DAT (median 1.7 vs. 0.8 years; p < 0.001) than those without recurrence. In COXproportional hazard analysis adjusted by confounders, the group with DAT ≥ 1 year, the optimal cutoff defined using receiver-operating characteristic curve analysis for recurrence, independently had a 2.3-fold greater risk of recurrence compared to the group without (p < 0.001). In a separate analysis with adjustment by confounders, paroxysmal and non-paroxysmal AF patients with DAT ≥ 1 year had 1.8-fold greater risk (p = 0.010) and 3.0-fold greater risk (p < 0.001), respectively, compared to those without. With respect to DAT-tertiles, paroxysmal AF patients in the top DAT-tertile (median 4.0 years) had 2.0-fold greater recurrence risk (p = 0.016), and non-paroxysmal AF patients in the top DAT-tertile had 4.0-fold greater recurrence risk, than those in the lowest DAT-tertile (p = 0.001).
CONCLUSION: AF patients with a longer DAT had a worse rhythm outcome after CA irrespective of AF type.